660
Views
10
CrossRef citations to date
0
Altmetric
Diabetes

A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone

, , , , , , , , , , & show all
Pages 693-699 | Received 23 Aug 2016, Accepted 21 Dec 2016, Published online: 25 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rui Ma, Xiao-long Deng, Qi-qi-ge Aleteng, Lei Li & Jun Zhu. (2022) Genome-Wide Transcriptome Analysis in Type 2 Diabetes Patients Treated by Sitagliptin. Diabetes, Metabolic Syndrome and Obesity 15, pages 1761-1770.
Read now

Articles from other publishers (9)

Lawrence Blonde, Guillermo E. Umpierrez, S. Sethu Reddy, Janet B. McGill, Sarah L. Berga, Michael Bush, Suchitra Chandrasekaran, Ralph A. DeFronzo, Daniel Einhorn, Rodolfo J. Galindo, Thomas W. Gardner, Rajesh Garg, W. Timothy Garvey, Irl B. Hirsch, Daniel L. Hurley, Kenneth Izuora, Mikhail Kosiborod, Darin Olson, Shailendra B. Patel, Rodica Pop-Busui, Archana R. Sadhu, Susan L. Samson, Carla Stec, William V. TamborlaneJr.Jr., Katherine R. Tuttle, Christine Twining, Adrian Vella, Priyathama Vellanki & Sandra L. Weber. (2022) American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice 28:10, pages 923-1049.
Crossref
Liyun He, Jialu Wang, Fan Ping, Na Yang, Jingyue Huang, Wei Li, Lingling Xu, Huabing Zhang & Yuxiu Li. (2022) Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials. BMJ, pages e068882.
Crossref
Brooke M. Currie, Timothy A. Howell, Louis S. Matza, David A. Cox & Joseph A. Johnston. (2021) A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and Opportunities. Diabetes Therapy 12:11, pages 2827-2856.
Crossref
Xin Liu, Suqin Wu, Jian Sun, Suiqin Ni, Laichun Lu, Wei Hu, Hua Wei, Yanqin Zou, Ting Li, Jintong Li, Bugela Mijiti, PingFei Fang, Limei Zhao, Huan Zhou, Xiaoming Xing, Haitao Niu & Yu Cao. (2021) Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010–2019. Pharmacology Research & Perspectives 9:2.
Crossref
Linong Ji, Juliana C. N. Chan, Miao Yu, Kun Ho Yoon, Sin Gon Kim, Sung Hee Choi, Chien‐Ning Huang, Shih Te Tu, Chih‐Yuan Wang, Päivi Maria Paldánius & Wayne H. H. Sheu. (2020) Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective . Diabetes, Obesity and Metabolism 23:1, pages 3-17.
Crossref
Sushrima GanAdem Y. Dawed, Louise A. DonnellyAnand T.N. NairColin N.A. PalmerViswanathan Mohan & Ewan R. Pearson. (2020) Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 43:8, pages 1948-1957.
Crossref
Weiping Jia, Jianping Weng, Dalong Zhu, Linong Ji, Juming Lu, Zhiguang Zhou, Dajin Zou, Lixin Guo, Qiuhe Ji, Li Chen, Liming Chen, Jingtao Dou, Xiaohui Guo, Hongyu Kuang, Ling Li, Qifu Li, Xiaoying Li, Jing Liu, Xingwu Ran, Lixin Shi, Guangyao Song, Xinhua Xiao, Liyong Yang & Zhigang Zhao. (2019) Standards of medical care for type 2 diabetes in China 2019. Diabetes/Metabolism Research and Reviews 35:6.
Crossref
Juan Ling, Peng Cheng, Long Ge, Ding-hua Zhang, An-chen Shi, Jin-hui Tian, Ya-jing Chen, Xiu-xia Li, Jing-yun Zhang & Ke-hu Yang. (2018) The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials. Acta Diabetologica 56:3, pages 249-272.
Crossref
Se Hee Min, Jeong-Hwa Yoon, Seokyung Hahn & Young Min Cho. (2018) Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis. Journal of Diabetes Investigation 9:4, pages 893-902.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.